Managing Diabetes to Gain Opportunities for a More Active Life
赞助:
University of Chicago
合作者:
信息的提供 (责任方):
,
追踪信息 | |||
---|---|---|---|
首次提交日期 ICMJE | September 20, 2018 | ||
首次发布日期e ICMJE | October 2, 2018 | ||
最后更新发布日期 | October 2, 2018 | ||
预计研究开始日期 ICMJE | October 2018 | ||
预计主要完成日期 | February 2020 (主要结果测量的最终数据收集日期) | ||
目前主要观察指标 ICMJE |
Documentation of Diabetes Goal[ Time Frame: 1 year ] Documentation of a personalized goal for diabetes care (e.g., A1C target) of diabetes care (yes or no). |
||
原始主要观察测量 ICMJE | 与当前相同 | ||
目前的二级观察 ICMJE |
|
||
描述性信息 | |||
简略标题 ICMJE | Managing Diabetes to Gain Opportunities for a More Active Life | ||
正式标题 ICMJE | Managing Diabetes to Gain Opportunities for a More Active Life (My Diabetes GOAL) | ||
简要概况 | The purpose of this novel patient-facing disease management intervention is to develop and test a system embedded within the electronic medical record to engage patients in personalized goal setting and chronic disease management. |
||
详细说明 | The purpose of this novel patient-facing disease management intervention, My Diabetes GOAL, is to develop and test a system embedded within the electronic medical record to engage patients in personalized goal setting and chronic disease management by: 1) establishing personalized goals of care based on comorbidities and preferences, 2) tracking diabetes measures against personalized goals, and 3) selecting the route and intensity of care management to help patients achieve their goals (e.g., telephonic care management, in-person care management, and self-care resources). This application can be used to individualize care, increase engagement with patient portals, and improve patient self-efficacy, as they take a more active role in their care. | ||
研究类型 ICMJE | Interventional | ||
研究阶段 | N/A | ||
研究设计 ICMJE | 分配: Randomized 干预模型: Parallel Assignment 干预模型描述: 盲法: Interventional 盲法描述: 主要目的: Supportive Care |
||
适用条件 ICMJE | |||
干预项目 ICMJE |
|
||
研究工具 |
|
||
招募信息 | |||
招募状态 ICMJE | Not yet recruiting | ||
预计入组 ICMJE |
100 | ||
原始预计入组 ICMJE | 与当前相同 | ||
预计研究完成日期 | June 2020 | ||
预计主要完成日期 | February 2020 (主要结果测量的最终数据收集日期) | ||
合格标准 ICMJE | Inclusion Criteria: - 65 years and older - Diagnosis of Type 2 Diabetes - Enrolled in MyChart (University of Chicago Patient Portal) - Outpatient clinic visit in the prior year Exclusion Criteria: - Under 64 years of age - No type 2 diabetes - Not enrolled in MyChart - No outpatient clinic visit in the prior year | ||
性别 |
|
||
年龄 | 最小年龄:65 Years ,最大年龄:N/A | ||
接受健康的志愿者 | 没有 | ||
可入组国家 ICMJE | |||
管理信息 | 数据检测委员会 | No | |
研究涉及美国FDA监管的产品 |
研究美国FDA监管的药品: No 研究涉及美国FDA监管的设备产品: No |
||
IPD 共享声明 |
|
||
责任方 | , | ||
研究赞助商 ICMJE | University of Chicago | ||
合作者 ICMJE | |||
研究员 ICMJE |
|
||
PRS 账户 | |||
验证日期 | September 2018 | ||
ICMJE 国际医学期刊编辑委员会和 世界卫生组织 ICTRP 要求的元素 |
请使用微信扫码报名